{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:17:19Z","timestamp":1785417439960,"version":"3.56.0"},"reference-count":23,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background: The Ahmed Glaucoma Valve (AGV) is a commonly used glaucoma drainage device (GDD) in the surgical management of glaucoma patients. Adjunctive mitomycin C (MMC) has demonstrated clear benefits in improving the surgical outcomes of trabeculectomy surgery. The effectiveness of MMC in improving the surgical outcomes of GDDs remains uncertain. This study seeks to compare the surgical outcomes of AGV implantation with and without the use of intraoperative MMC in an African cohort.\nMethods: This retrospective case series analysed 98 eyes in 95 patients who underwent AGV implantation from 01 January 2016 to 31 December 2021 at two units located in Cape Town, South Africa. The postoperative data collected included intraocular pressure (IOP), medication use, and complications.\nResults: The eyes were categorised into the MMC use (n = 46) or non-MMC use (n = 52) group. In most eyes within the MMC use group (78.3%, n = 36), a concentration of 0.2 mg\/mL was used. The mean preoperative IOP in the MMC group and the non-MMC group was 38 and 33, respectively (p = 0.12). At 1 year, the mean IOP in the MMC use group (n = 31) was 18 mmHg and 16 mmHg in the non-MMC group (n = 36) (p = 0.84). The frequency of complications and the hypertensive phase were comparable in the two groups.\nConclusion: This study found no difference between the two groups in terms of IOP control, postoperative medication use, and complications. This may be attributed to the low concentration of MMC used in our cohort.\nContribution: This study provides insights into the role of MMC use in AGV implantation.<\/jats:p>","DOI":"10.4102\/jcmsa.v4i1.362","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:40:57Z","timestamp":1779457257000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C"],"prefix":"10.4102","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-0575","authenticated-orcid":false,"given":"Hojatollah","family":"Jaldi","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4712-453X","authenticated-orcid":false,"given":"Tshilidzi","family":"van der Lecq","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Foo VHX, Htoon HM, Welsbie DS, Perera SA. Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. Cochrane Database Syst Rev. 2019;4(4):CD011875. https:\/\/doi.org\/10.1002\/14651858.CD011875.pub2","DOI":"10.1002\/14651858.CD011875.pub2"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest glaucoma trial: Design and baseline data. Ophthalmology. 1999;106(11):2144\u20132153. https:\/\/doi.org\/10.1016\/S0161-6420(99)90497-9","DOI":"10.1016\/S0161-6420(99)90497-9"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Purtskhvanidze K, Saeger M, Treumer F, Roider J, N\u00f6lle B. Long-term results of glaucoma drainage device surgery. BMC Ophthalmol. 2019;19(1):14. https:\/\/doi.org\/10.1186\/s12886-019-1027-z","DOI":"10.1186\/s12886-019-1027-z"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Arikan G, Gunenc U. Ahmed glaucoma valve implantation to reduce intraocular pressure: Updated perspectives. Clin Ophthalmol. 2023;17:1833\u20131845. https:\/\/doi.org\/10.2147\/OPTH.S342721","DOI":"10.2147\/OPTH.S342721"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Cui QN, Hsia YC, Lin SC, et al. Effect of mitomycin C and 5-fluorouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. Clin Exp Ophthalmol. 2017;45(2):128\u2013134. https:\/\/doi.org\/10.1111\/ceo.12811","DOI":"10.1111\/ceo.12811"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Awad-Allah MAA, Mousa AS, Ashour DM. The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results. Graefes Arch Clin Exp Ophthalmol. 2023;261(8):2343\u20132349. https:\/\/doi.org\/10.1007\/s00417-023-06019-y","DOI":"10.1007\/s00417-023-06019-y"},{"key":"ref6","unstructured":"Swampillai AJ, Nagar A, Sherman T, et al. Primary glaucoma surgery for African and African-Caribbean patients (PEACE): A pilot randomised controlled trial. Invest Ophthalmol Vis Sci. 2023;64(8):4278."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Yazdani S, Mahboobipour H, Pakravan M, Doozandeh A, Ghahari E. Adjunctive mitomycin C or amniotic membrane transplantation for Ahmed glaucoma valve implantation: A randomized clinical trial. J Glaucoma. 2016;25(5):415\u2013421. https:\/\/doi.org\/10.1097\/IJG.0000000000000256","DOI":"10.1097\/IJG.0000000000000256"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: Long-term outcomes. Am J Ophthalmol. 2008;146(2):276\u2013284. https:\/\/doi.org\/10.1016\/j.ajo.2008.04.008","DOI":"10.1016\/j.ajo.2008.04.008"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Figueiredo R, Barbosa-Breda J. The efficacy of adjunctive mitomycin C and\/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: A systematic review. Graefes Arch Clin Exp Ophthalmol. 2024;262(10):3273\u20133286. https:\/\/doi.org\/10.1007\/s00417-024-06476-z","DOI":"10.1007\/s00417-024-06476-z"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Perez CI, Verdaguer S, Khaliliyeh D, Maul EA, Ou Y, Han Y. Subconjunctival injections of mitomycin C are associated with a lower incidence of hypertensive phase in eyes with Ahmed glaucoma valve. Ophthalmol Glaucoma. 2021;4(3):322\u2013329. https:\/\/doi.org\/10.1016\/j.ogla.2020.10.004","DOI":"10.1016\/j.ogla.2020.10.004"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"De Sousa Peixoto R, Saravananan A, Selvan H, et al. Baerveldt aqueous shunt with or without mitomycin C augmentation: A retrospective comparison study. Ophthalmol Glaucoma. 2023;6(4):358\u2013365. https:\/\/doi.org\/10.1016\/j.ogla.2022.11.007","DOI":"10.1016\/j.ogla.2022.11.007"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Promelle V, Lyons CJ. Long-term results of Ahmed valve implantation with mitomycin-C in pediatric glaucoma. J Glaucoma. 2021;30(7):596\u2013605. https:\/\/doi.org\/10.1097\/IJG.0000000000001881","DOI":"10.1097\/IJG.0000000000001881"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mahdy R. Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma. J Glaucoma. 2011;20(7):458\u2013463. https:\/\/doi.org\/10.1097\/IJG.0b013e3181efbea5","DOI":"10.1097\/IJG.0b013e3181efbea5"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Zhou M, Wang W, Huang WB, Zhang X. Use of mitomycin C to reduce the incidence of encapsulated cysts following Ahmed glaucoma valve implantation in refractory glaucoma patients: A new technique. BMC Ophthalmol. 2014;14:107. https:\/\/doi.org\/10.1186\/1471-2415-14-107","DOI":"10.1186\/1471-2415-14-107"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kook MS, Yoon J, Kim J, Lee M. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C. Ophthalmic Surg Lasers. 2000;31(2):100\u2013106. https:\/\/doi.org\/10.3928\/1542-8877-20000301-05","DOI":"10.3928\/1542-8877-20000301-05"},{"key":"ref16","unstructured":"Tien MCH, Yip LW, Wong EPY, Yong VKY, Wong HT, Lim BA. The effect of adjuvant mitomycin C in Ahmed glaucoma valve surgery for refractory glaucoma. Invest Ophthalmol Vis Sci. 2013;54:4771."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kim NE, Kim SS, Lee JS, et al. Effect of intraoperative mitomycin C on the surgical outcomes of Ahmed glaucoma valve implantation with ciliary sulcus tube placement. Korean J Ophthalmol. 2023;37(3):216\u2013223. https:\/\/doi.org\/10.3341\/kjo.2022.0146","DOI":"10.3341\/kjo.2022.0146"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: A prospective randomized clinical trial. Ophthalmology. 2004;111(6):1071\u20131076. https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.037","DOI":"10.1016\/j.ophtha.2003.09.037"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Kurnaz E, Kubaloglu A, Yilmaz Y, Koytak A, Ozert\u00fcrk Y. The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation. Eur J Ophthalmol. 2005;15(1):27\u201331. https:\/\/doi.org\/10.1177\/112067210501500105","DOI":"10.1177\/112067210501500105"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Nguyen AH, Fatehi N, Romero P, et al. Observational outcomes of initial trabeculectomy with mitomycin C in patients of African Descent vs Patients of European Descent: Five-year results. JAMA Ophthalmol. 2018;136(10):1106\u20131113. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2897","DOI":"10.1001\/jamaophthalmol.2018.2897"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Akova YA, Ko\u00e7 F, Yalva\u00e7 I, Duman S. Scleromalacia following trabeculectomy with intraoperative mitomycin C. Eur J Ophthalmol. 1999;9(1):63\u201365. https:\/\/doi.org\/10.1177\/112067219900900110","DOI":"10.1177\/112067219900900110"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Christakis PG, Kalenak JW, Tsai JC, et al. The Ahmed versus Baerveldt study: Five-year treatment outcomes. Ophthalmology. 2016;123(10):2093\u20132102. https:\/\/doi.org\/10.1016\/j.ophtha.2016.06.035","DOI":"10.1016\/j.ophtha.2016.06.035"}],"container-title":["Journal of the Colleges of Medicine of South Africa"],"original-title":[],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:41:06Z","timestamp":1779457266000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/jcmsa.v4i1.362","relation":{},"ISSN":["3105-4331","2960-110X"],"issn-type":[{"value":"3105-4331","type":"print"},{"value":"2960-110X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"a362"}}